GlassScriptPhysician profile
Nirguna R Thalla
NPI 1366903056
$2,485.14
in general payments reported to CMS, 2019-2025
19 companies · $1,236 in 2025
The $1,236 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,249 · 2025: $1,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,721 · Travel and Lodging: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,721.08 |
| Travel and Lodging | $764.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $602.31 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $573.78 | 2024-2025 | Proclaim, Eterna |
| Nalu Medical, INC. | $183.84 | 2025 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $167.79 | 2025 | Intracept Rf Probe, Wavewriter Alpha Prime 16 |
| Painteq LLC | $156.77 | 2024 | Painteq |
| Hydrocision, INC. | $150.00 | 2024 | Tenjet |
| Spr Therapeutics, INC | $115.15 | 2025 | Sprint Pns System |
| Globus Medical, INC. | $95.23 | 2025 | Senza |
| Amgen INC. | $86.15 | 2025 | Krystexxa |
| Stryker Corporation | $67.63 | 2024-2025 | Mild Device Kit, Spinejack |
| Alexion Pharmaceuticals, INC. | $46.29 | 2025 | Strensiq |
| Ucb, INC. | $41.54 | 2025 | Bimzelx |
| Pacira Pharmaceuticals Incorporated | $41.05 | 2025 | Iovera, Zilretta, Exparel |
| Radius Health, INC. | $40.81 | 2025 | Tymlos |
| Nevro Corp. | $29.52 | 2024 | Senza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $29.36 | 2025 | |
| Tersera Therapeutics LLC | $21.89 | 2024 | Prialt |
| Janssen Biotech, INC. | $19.12 | 2025 | Tremfya |
| Mallinckrodt Hospital Products INC. | $16.91 | 2025 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirguna Thalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.